In addition, aPBAE/Cas9-CDK5 nanoparticles developed by Huan Deng et al. can effectively knock out CDK5 in vitro, resulting in down-regulation of PD-L1 expression and inhibition of tumor growth [74]. Here, CDK5 is linked to neoplasm.